Conclusion
Interferon shows promising results when used for the treatment of polycythemia vera with a durable hematologic and molecular response and has an acceptable side effects profile. However, large randomized clinical trials are needed to confirm these findings and to explore the dose and combination of interferon with other drugs..
FDA Issues Complete Response Letter for Ropeginterferon Alfa-2b for Polycythemia Vera
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemiaPolycythemia Vera Management Often Does Not Follow GuidelinesFDA Rejects Ropeginterferon alfa-2b for Polycythemia Vera
Just been diagnosed with Polycythemia Vera
